BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11278743)

  • 1. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
    Scarsdale JN; Kazanina G; He X; Reynolds KA; Wright HT
    J Biol Chem; 2001 Jun; 276(23):20516-22. PubMed ID: 11278743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
    Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
    J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
    Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
    J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis.
    Choi KH; Kremer L; Besra GS; Rock CO
    J Biol Chem; 2000 Sep; 275(36):28201-7. PubMed ID: 10840036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
    Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
    J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing reactivity and substrate specificity of both subunits of the dimeric Mycobacterium tuberculosis FabH using alkyl-CoA disulfide inhibitors and acyl-CoA substrates.
    Sachdeva S; Musayev F; Alhamadsheh MM; Neel Scarsdale J; Tonie Wright H; Reynolds KA
    Bioorg Chem; 2008 Apr; 36(2):85-90. PubMed ID: 18096200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
    Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
    J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.
    Sachdeva S; Musayev FN; Alhamadsheh MM; Scarsdale JN; Wright HT; Reynolds KA
    Chem Biol; 2008 Apr; 15(4):402-12. PubMed ID: 18420147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
    Sachdeva S; Reynolds KA
    Methods Mol Med; 2008; 142():205-13. PubMed ID: 18437316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine.
    Witkowski A; Joshi AK; Lindqvist Y; Smith S
    Biochemistry; 1999 Sep; 38(36):11643-50. PubMed ID: 10512619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1996 May; 271(18):10996-1000. PubMed ID: 8631920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
    von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
    FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the fatty acid profile of Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl acyl carrier protein synthase III (FabH).
    Li Y; Florova G; Reynolds KA
    J Bacteriol; 2005 Jun; 187(11):3795-9. PubMed ID: 15901703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes involved in fatty acid and polyketide biosynthesis in Streptomyces glaucescens: role of FabH and FabD and their acyl carrier protein specificity.
    Florova G; Kazanina G; Reynolds KA
    Biochemistry; 2002 Aug; 41(33):10462-71. PubMed ID: 12173933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
    Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
    J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
    He X; Reynolds KA
    Antimicrob Agents Chemother; 2002 May; 46(5):1310-8. PubMed ID: 11959561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.